ALPMY - Astellas Announces a Collaboration with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of Pharmaceutical and Robotics Technologies | Benzinga
- Focuses on digitizing cell manufacturing processes through robotics technology
TOKYO, May 21, 2024 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it signed a memorandum of understanding with YASKAWA Electric Corporation (YASKAWA) to begin discussions on the creation of an innovative cell therapy ecosystem through the integration of pharmaceutical and robotics technologies. This memorandum is legally non-binding and will lead to further specific discussions between the two companies in the future.
The complexity of product manufacturing is a significant challenge to commercializing cell therapy. Substantial investments are required to develop complex manufacturing processes, transfer technology among manufacturers, and establish large-scale manufacturing facilities for commercialization. This makes it difficult ...